NDC 0006-0461 – Emend
Aprepitant 80 mg/1 · Capsule · Oral
Product NDC0006-0461
Product details
- Brand name
- Emend
- Generic name
- Aprepitant
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA021549
- Marketed since
- March 26, 2003
- Listing expires
- December 31, 2026
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Aprepitant 80 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0006-0461-02 | 2 CAPSULE in 1 DOSE PACK (0006-0461-02) | Mar 26, 2003 |
| 0006-0461-12 | 2 CAPSULE in 1 DOSE PACK (0006-0461-12) | Mar 26, 2003 |
Recalls mentioning this NDC
- D-0241-2026 Dec 31, 2025 · Class II
Presence of particulate matter: potential presence of metal particulates in the product.
Other Emend products
- 0006-0462 Aprepitant 125 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0006-0464 Aprepitant 40 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0006-3061 Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Merck Sharp & Dohme LLC
- 0006-3066 Aprepitant 125 mg/1 · Powder, For Suspension · Merck Sharp & Dohme LLC
- 0006-3862 · Kit · Merck Sharp & Dohme LLC